NXTC - NextCure, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/2017
Total Revenue--
Cost of Revenue--
Gross Profit--
Operating Expenses
Research Development19,78712,954
Selling General and Administrative3,4092,595
Non Recurring--
Others--
Total Operating Expenses23,19615,549
Operating Income or Loss-23,196-15,549
Income from Continuing Operations
Total Other Income/Expenses Net39780
Earnings Before Interest and Taxes-23,196-15,549
Interest Expense-25-30
Income Before Tax-22,799-15,469
Income Tax Expense--
Minority Interest--
Net Income From Continuing Ops-22,799-15,469
Non-recurring Events
Discontinued Operations--
Extraordinary Items--
Effect Of Accounting Changes--
Other Items--
Net Income
Net Income-22,799-15,469
Preferred Stock And Other Adjustments--
Net Income Applicable To Common Shares-22,799-15,469